The National CKD Audit: a primary care condition that deserves more attention. by Hull, Sally A et al.
LSHTM Research Online
Hull, SA; Nitsch, D; Caplin, B; Griffith, K; Wheeler, DC; (2018) The National CKD Audit: a primary
care condition that deserves more attention. The British journal of general practice, 68 (673). pp.
356-357. ISSN 0960-1643 DOI: https://doi.org/10.3399/bjgp18X697997
Downloaded from: http://researchonline.lshtm.ac.uk/4648718/
DOI: https://doi.org/10.3399/bjgp18X697997
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: Copyright the publishers
https://researchonline.lshtm.ac.uk
INTRODUCTION
Chronic kidney disease (CKD) is a common 
condition, with an estimated prevalence 
in the UK of around 5–7%,1,2 and a GP 
recorded prevalence in the England Quality 
and Outcomes Framework (QOF) in 2017 of 
4.1%,3 which is higher than the prevalence 
of coronary heart disease.
The majority of people with CKD are 
detected and managed in primary care 
rather than by kidney specialists. Early 
identification in primary care, particularly 
among populations with risk factors such 
as diabetes and hypertension, enables 
appropriate management of blood pressure, 
cardiovascular risk and lifestyle factors. 
There is evidence that progression of CKD 
can be delayed by such interventions,4 and 
that implementation of these interventions 
can be improved by use of quality 
improvement tools in primary care.5 
However CKD as a long-term condition 
has not had an easy ride. Since its definition 
in 2002 there have been concerns about 
overdiagnosis, described as ‘when people 
without symptoms are diagnosed with a 
disease that ultimately will not cause them 
symptoms or early death’,6 and anxieties 
about the disclosure of early-stage CKD to 
patients, along with the work of reassurance 
and increased monitoring that this might 
entail.7,8 This debate within general practice 
has left some practitioners uncertain about 
the importance of naming, coding and 
managing CKD in primary care. 
THE NATIONAL CHRONIC KIDNEY 
DISEASE AUDIT
This national audit, commissioned by 
the Healthcare Quality Improvement 
Partnership (HQIP) in 2014 as part of 
the National Clinical Audit and Patient 
Outcomes Programme, was designed to 
improve the identification and management 
of CKD in primary care. The audit included 
data from over 1000 practices in England 
and Wales, producing the largest sample 
of patients with CKD globally, the dataset 
for analysis of hospital outcomes included 
over 400 000 records of patients with CKD. 
Alongside data extraction to examine 
practice performance against NICE 
guidance and quality standards,9,10 an 
electronic quality improvement tool was 
developed. This provided in-consultation 
prompts, and practice lists of people who 
might benefit from attention to blood 
pressure management and other key 
interventions for CKD. 
Part one of the audit report had a focus 
on findings relating to CKD identification, 
diagnostic coding, and management in 
primary care.1 The audit found high rates of 
regular testing among people with diabetes 
— no doubt a result of the reminders and 
incentives provided by QOF — this finding 
was in contrast to lower testing rates 
for those with hypertension in spite of a 
similar or higher prevalence of CKD among 
this population. Less than 30% of those 
with hypertension had urinary testing for 
albumin to creatinine ratio (ACR), a marker 
for higher risk of cardiovascular disease 
and more rapid CKD progression, and 
hence a reminder of the need for regular 
review and to manage blood pressure to 
tighter targets.
Across the 1000 audit practices, rates 
of diagnostic coding for CKD showed 
wide variation, with a range of 20% to 
100% of biochemically identifiable cases. 
Of some concern was the finding that 
younger people (those aged <60 years) 
who had biochemical evidence of CKD 
had lower rates of CKD coding than those 
aged >60 years. These younger patients, 
particularly those with diabetes, have 
perhaps the most to gain from regular CKD 
review, an offer of treatment with statin, and 
control of blood pressure. 
The second part of the audit, published 
in December 2017, looked at the outcomes 
of people with CKD, including emergency 
hospital admission, rates of acute kidney 
injury at hospital admission (AKI) and 
death.11
The rates of unplanned hospital 
admission, for all causes, increase sharply 
with a progressive fall in eGFR value such 
that patients with stage 4 CKD have around 
twice the unplanned hospital admission 
rate of those with stage 3 CKD. By using 
the linked data from primary and secondary 
care records the audit was also able to 
show that emergency hospital admission is 
more likely among people with biochemical 
evidence of CKD when this has not been 
previously coded in primary care. The 
magnitude of this difference in admission 
rates between coded and uncoded patients 
increases as kidney function declines, with 
twice the admission rates between coded 
and uncoded cases as the eGFR declines 
below 35ml/min (Figure 1).
Admission rates for acute kidney injury 
(AKI) showed a fourfold rise as CKD status 
declines from stage 3 to stage 4. Similar 
evidence was found to suggest that CKD 
coding is associated with lower rates of 
admission. Mortality rates showed a broadly 
similar pattern.
These observations of associations 
between CKD coding and unplanned hospital 
admissions is intriguing and important. For 
the present it needs treating with some 
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Figure 1. Comparison of emergency admissions between uncoded and coded patients with biochemical CKD stages 
3–5 (using rate ratios). All rates are adjusted by age, sex, diabetes, hypertension, and cardiovascular disease.
caution, as the National Chronic Kidney 
(NCKD) database did not include data on 
all primary care coded comorbidities, and 
some important attributes that contribute 
to morbidity such as patient frailty, are 
currently not well captured by coded data. 
Further studies using a range of primary 
care and hospital linked data are needed 
to address these questions, and establish 
whether there is a causal link between 
improving rates of diagnostic coding and 
adverse events including emergency 
admission and death.
IMPLICATIONS FOR PRACTICE
The audit recommendations include 
a call to general practice to identify and 
test patients at risk, and where there is 
evidence of CKD stages 3–5 to improve 
the coding and regular review of these 
patients. There is good evidence, both 
from the national audit and from other 
studies, that coding is associated with 
improvements in the process of care. The 
benefits include managing blood pressure 
to target, the prescription of statins for 
primary prevention of cardiovascular 
disease, monitoring urinary proteinuria, 
and provision of flu and pneumococcal 
immunisation.12,13 Disease coding in primary 
care is a proxy for increased clinical scrutiny 
and informed clinical decision making with 
these patients, who often have a range of 
other comorbidities which increase their 
vulnerability to AKI and their likelihood of 
unplanned hospital admission. Although 
the national audit did not include data on 
medications that are potentially harmful 
to the kidneys such as non-steroidal anti-
inflammatory medications (NSAID) there 
are important links between coding for CKD 
and safe prescribing. Some, but not all, GP 
computer systems link prescribing alerts 
to coded diagnoses — hence the benefits 
of these safety alerts are not available to 
uncoded patients.
ACHIEVING CHANGE
The national CKD audit highlights the wide 
variation between practices in their rates of 
CKD coding and the clinical management 
associated with best delivery of primary 
care. Many practices already use audit tools 
to monitor and improve their performance; 
others may need additional support or 
incentives to compare their performance 
with others and raise their game. Clinical 
commissioning groups and local health 
boards have an important role in providing 
the tools and resources to support this 
activity, which will provide direct benefits 
for patient care and are likely to result in 
decreased rates of hospital admission for 
this vulnerable group of patients.
Sally A Hull,
Reader in Primary Care Development, Queen Mary 
University of London, London.
Dorothea Nitsch,
Professor of Clinical Epidemiology and Honorary 
Consultant, London School of Hygiene and Tropical 
Medicine, London.
Ben Caplin,
Senior Clinical Lecturer and Honorary Consultant, 
University College London Centre for Nephrology, 
London.
Kathryn Griffith,
GP, Vale of York CCG, RCGP Clinical Lead for Kidney 
Care, York.
David C Wheeler
Professor of Kidney Medicine, University College 
London Centre for Nephrology, London.
Provenance
Commissioned; not externally peer reviewed.
Competing interests
The authors have declared no competing interests.
DOI: https://doi.org/10.3399/bjgp18X697997
British Journal of General Practice, August 2018  357
ADDRESS FOR CORRESPONDENCE
Sally A Hull 
Barts and The London School of Medicine and 
Dentistry, Centre for Primary Care and Public 
Health, 58 Turner Street, Whitechapel, London E1 
2AB, UK.
Email: s.a.hull@qmul.ac.uk
REFERENCES
1. Nitsch D, Caplin B, Hull SA, et al. National 
Chronic Kidney Disease Audit: National Report 
(Part 1) 2017. Healthcare Quality Improvement 
Partnership, 2017.
2. Iwagami M, Tomlinson LA, Mansfield KE, et al. 
Validity of estimated prevalence of decreased 
kidney function and renal replacement therapy 
from primary care electronic health records 
compared with national survey and registry data 
in the United Kingdom. Nephrol Dial Transplant 
2017; 32(suppl 2): ii142-ii50.
3. Quality and Outcomes Framework. QOF 2016/17 
results. NHS Digital, 2017. 
4. Lv J, Ehteshami P, Sarnak MJ, et al. Effects 
of intensive blood pressure lowering on the 
progression of chronic kidney disease: a 
systematic review and meta-analysis. CMAJ 
2013; 185(11): 949-957. 
5. Lusignan S, Gallagher H, Jones S, , et al. 
Audit-based education lowers systolic blood 
pressure in chronic kidney disease: the Quality 
Improvement in CKD (QI CKD) trial results. 
Kidney Int 2013; 84(3): 609-620. 
6. Treadwell J, McCartney M. Overdiagnosis and 
overtreatment: generalists--it’s time for a 
grassroots revolution. Br J Gen Pract 2016; DOI: 
https://doi.org/10.3399/bjgp16X683881.
7. Blakeman T, Protheroe J, Chew-Graham C, et 
al. Understanding the management of early-
stage chronic kidney disease in primary care: 
a qualitative study. Br J Gen Pract 2012; DOI: 
https://doi.org/10.3399/bjgp12X636056. 
8. Daker-White G, Rogers A, Kennedy A, et al. 
Non-disclosure of chronic kidney disease in 
primary care and the limits of instrumental 
rationality in chronic illness self-management. 
Soc Sci Med 2015; 131: 31–39.
9. National Institute for Health and Care 
Excellence. Chronic kidney disease: (partial 
update) early identification and management of 
chronic kidney disease in adults in primary and 
secondary care. NICE, 2014.
10. National Institute for Health and Care 
Excellence. Chronic kidney disease in adults: 
Quality standard. NICE, 2011.
11. Cleary F, Kim LG, Caplin B, et al National 
Chronic Kidney Disease Audit. National Report 
(Part 2) 2017. Healthcare Quality Improvement 
Partnership, 2017. 
12. Jain P, Calvert M, Cockwell P, McManus 
RJ. The need for improved identification and 
accurate classification of stages 3-5 Chronic 
Kidney Disease in primary care: retrospective 
cohort study. PloS One 2014; 9(8): e100831.
13. Kim LG, Cleary F, Wheeler DC, et al. How do 
primary care doctors in England and Wales 
code and manage people with chronic kidney 
disease? Results from the National Chronic 
Kidney Disease Audit. Nephrology, dialysis, 
transplantation 2017; DOI: 10.1093/ndt/gfx280.
“… emergency hospital admission is more likely 
among people with biochemical evidence of CKD 
when this has not been previously coded in primary 
care.”
